Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Postcoital bleeding in women

Mark Shapley, DM, DCH, DRCOG, FRCGP
Section Editor
Robert L Barbieri, MD
Deputy Editor
Sandy J Falk, MD, FACOG


Postcoital bleeding refers to spotting or bleeding unrelated to menstruation that occurs during or after sexual intercourse. It can be a sign of serious underlying pathology and is usually alarming for patients. About one-third of patients also have abnormal uterine bleeding that is not associated with coitus and about 15 percent have dyspareunia [1,2].

This topic will discuss causes of postcoital bleeding, the likelihood that cancer is the cause, and an approach to management. Other causes of abnormal uterine bleeding and evaluation of women with other types of abnormal uterine bleeding can be found separately. (See "Approach to abnormal uterine bleeding in nonpregnant reproductive-age women".)


Postcoital bleeding, while uncommon, is not rare in community populations. The point prevalence determined in large community surveys using self-completed questionnaires ranges from 0.7 to 9 percent [3,4]. One study reported an annual cumulative incidence of about 6 percent of menstruating women [5]. Another reported a prevalence of 5 percent among patients being seen in a hospital's obstetrics and gynecology outpatient department [6]. These disparities are due to variations in study design, including differences in symptom definition, time range in which the symptom occurred (past month to six months), frequency (ever versus frequently), age distribution of the population, and prevalence of sexually transmitted infection and use of hormones. In addition, some studies included women not having sexual relations in the study population.

In naturally menstruating women, the two-year cumulative incidence of postcoital bleeding has been reported as 8 percent with high rates of spontaneous resolution (51 percent for two years without recurrence) [7].


Cervical cancer — The most serious cause of postcoital bleeding is cervical cancer. About 11 percent of women with cervical cancer present with postcoital bleeding (range 0.7 to 39 percent) [8]. The proportion of women with cervical cancer who present with bleeding has fallen over time, probably due to widespread use of screening programs that identify premalignant and malignant cervical disease. It is generally felt that premalignant disease is asymptomatic because cervical intraepithelial neoplasia is very superficial and differs from cervical cancer in that the neoplastic lesions does not have their own blood supply [9,10].

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information on subscription options, click below on the option that best describes you:

Subscribers log in here

Literature review current through: Nov 2017. | This topic last updated: Dec 01, 2017.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2017 UpToDate, Inc.
  1. Tehranian A, Rezaii N, Mohit M, et al. Evaluation of women presenting with postcoital bleeding by cytology and colposcopy. Int J Gynaecol Obstet 2009; 105:18.
  2. Selo-Ojeme DO, Dayoub N, Patel A, Metha M. A clinico-pathological study of postcoital bleeding. Arch Gynecol Obstet 2004; 270:34.
  3. Viikki M, Pukkala E, Hakama M. Bleeding symptoms and subsequent risk of gynecological and other cancers. Acta Obstet Gynecol Scand 1998; 77:564.
  4. Lindner LE, Geerling S, Nettum JA, et al. Clinical characteristics of women with chlamydial cervicitis. J Reprod Med 1988; 33:684.
  5. Shapley M, Jordan K, Croft PR. An epidemiological survey of symptoms of menstrual loss in the community. Br J Gen Pract 2004; 54:359.
  6. Bax CJ, Oostvogel PM, Mutsaers JA, et al. Clinical characteristics of Chlamydia trachomatis infections in a general outpatient department of obstetrics and gynaecology in the Netherlands. Sex Transm Infect 2002; 78:E6.
  7. Shapley M, Blagojevic-Bucknall M, Jordan KP, Croft PR. The epidemiology of self-reported intermenstrual and postcoital bleeding in the perimenopausal years. BJOG 2013; 120:1348.
  8. Shapley M, Jordan J, Croft PR. A systematic review of postcoital bleeding and risk of cervical cancer. Br J Gen Pract 2006; 56:453.
  9. Pretorius R, Semrad N, Watring W, Fotheringham N. Presentation of cervical cancer. Gynecol Oncol 1991; 42:48.
  10. Khan Z, Appleton F, Turner J. Is cervical intra-epithelial neoplasia symptomatic? J Obstet Gynaecol 2008; 28:336.
  11. Hakama M, Joutsenlahti U, Virtanen A, Räsänen-Virtanen U. Mass screenings for cervical cancer in Finland 1963-71. Organization, extent, and epidemiological implications. Ann Clin Res 1975; 7:101.
  12. Rosenthal AN, Panoskaltsis T, Smith T, Soutter WP. The frequency of significant pathology in women attending a general gynaecological service for postcoital bleeding. BJOG 2001; 108:103.
  13. Goldacre MJ, Loudon N, Watt B, et al. Epidemiology and clinical significance of cervical erosion in women attending a family planning clinic. Br Med J 1978; 1:748.
  14. Götz HM, van Bergen JE, Veldhuijzen IK, et al. A prediction rule for selective screening of Chlamydia trachomatis infection. Sex Transm Infect 2005; 81:24.
  15. Verhoeven V, Avonts D, Meheus A, et al. Chlamydial infection: an accurate model for opportunistic screening in general practice. Sex Transm Infect 2003; 79:313.
  16. Padian NS, Abrams J, Skurnick JH, et al. Risk factors for postcoital bleeding among women with or at risk for infection with human immunodeficiency virus. J Infect Dis 1995; 172:1084.
  17. Sahu B, Latheef R, Aboel Magd S. Prevalence of pathology in women attending colposcopy for postcoital bleeding with negative cytology. Arch Gynecol Obstet 2007; 276:471.
  18. Guimarães MD, Vlahov D, Castilho EA. Postcoital vaginal bleeding as a risk factor for transmission of the human immunodeficiency virus in a heterosexual partner study in Brazil. Rio de Janeiro Heterosexual Study Group. Arch Intern Med 1997; 157:1362.
  19. Ellerbrock TV, Wright TC, Bush TJ, et al. Characteristics of menstruation in women infected with human immunodeficiency virus. Obstet Gynecol 1996; 87:1030.
  20. Mawajdeh SM, Al-Qutob RJ, Farag AM. Prevalence and risk factors of genital prolapse. A multicenter study. Saudi Med J 2003; 24:161.
  21. Gupta R, Singh S, Nigam S, Khurana N. Benign vascular tumors of female genital tract. Int J Gynecol Cancer 2006; 16:1195.
  22. Alfhaily F, Ewies AA. Postcoital bleeding: a study of the current practice amongst consultants in the United Kingdom. Eur J Obstet Gynecol Reprod Biol 2009; 144:72.
  23. Jha S, Sabharwal S. Outcome of colposcopy in women presenting with postcoital bleeding and negative or no cytology--results of a 1-year audit. J Obstet Gynaecol 2002; 22:299.
  24. NHS Executive. Referral Guidelines for Suspected Cancer. Department of Health, London 2000.
  25. Khattab AF, Ewies AA, Appleby D, Cruickshank DJ. The outcome of referral with postcoital bleeding (PCB). J Obstet Gynaecol 2005; 25:279.
  26. Fraser IS, Petrucco OM. Management of intermenstrual and postcoital bleeding, and an appreciation of the issues arising out of the recent case of O'Shea versus Sullivan and Macquarie pathology. Aust N Z J Obstet Gynaecol 1996; 36:67.
  27. National Health Service Cervical Screening Programme (NHSCSP). Colposcopy and Programme Management Guidelines for the NHS Cervical Screening Programme 2010; p. 16 (item 4.11). http://www.cancerscreening.nhs.uk/cervical/publications/nhscsp20.pdf (Accessed on June 18, 2015).
  28. Kong GW, Yim SF, Cheung TH, Chung TK. Cryotherapy as the treatment modality of postcoital bleeding: a randomised clinical trial of efficacy and safety. Aust N Z J Obstet Gynaecol 2009; 49:517.